Exemestane | Radio Compass News

Qilu Pharm`s Generic Exemestane Receives Approval in US

16 Apr 2020 //

FDA

Mayne Pharma’s Generic Exemestane Receives Approval In US

13 Aug 2019 //

FDA

Amneal Pharms` Generic Exemestane Receives Approval in US

31 Dec 2018 //

FDA

Zydus Pharms USA`s Generic Exemestane Receives Approval in US

04 Oct 2018 //

FDA

Cipla gets USFDA nod for generic equivalents of Vazculep, Aromasin

01 May 2018 //

THE HINDUBUSINESSLINE

Cipla’s Generic Exemestane Receives Approval In US

01 May 2018 //

FDA

Upsher-Smith Launches Generic Version Of Aromasin® (Exemestane) Tablets

11 Oct 2017 //

PR NEWSWIRE

Upsher-Smith’s Generic Exemestane Receives Approval In US

31 Jul 2017 //

FDA

Mylan Pharm’s Generic Exemestane Receives Approval In US

10 Mar 2017 //

FDA

Anvisa approves drugs for cancer and polio vaccine to 1.2 and 3

11 Jan 2016 //

ANVISA

Attix Pharmaceuticals Recalls Hundreds of APIs From the U.S.

02 May 2015 //

FIERCE PHARMA MFG

Novartis Announces Results of Trial Evaluating the Use of Afinitor® in First-line Treatment in HER2+ Advanced Breast Cancer at SABCS

12 Dec 2014 //

FINANZEN.NET

NEWS

DRUGS & DEVELOPMENTS

MARKET INTEL by PharmaCompass